Demystifying the World's Largest Medtech Market
Understanding U.S. Coding, Coverage and Reimbursement Models
Recording Coming Soon
September 13, 2022
9am EDT / 1pm GMT
The United States has long been medtech’s largest and most complex market. For manufacturers and distributors considering entry to the U.S. market, true and comprehensive preparation is more important than ever. This involves extensive market analysis, a deep understanding of regulatory requirements, and other potentially difficult measures. So how can you set yourself up for success?
In part two of our U.S. series, learn from experts Jayson Slotnik and Dr. Joel Brill about the building blocks of a reimbursement strategy including an overview of codes and types, coverage fundamentals and payment mechanisms.
Attendees will learn:
- What factors affect the development of new medical technology
- The tops myths surrounding reimbursement in the U.S. market
- The five key elements of reimbursement
Meet our speakers:
Dr. Joel Brill, Chief Medical Officer, Predictive Health
Joel Brill, MD FACP has over 30 years of experience providing strategic leadership and medical oversight to large data-driven health organizations. He is skilled in strategy, development and implementation of innovative health programs, products and payment systems, with extensive experience in clinical practice, research, coverage, reimbursement, quality improvement, data analysis, and value-based care. Dr. Brill has run risk-bearing Independent Practice Associations and Physician-Hospital Organizations in California and Arizona, held management positions with and participates on committees for several managed care companies.
Jayson S. Slotnik, Principal, Health Policy Strategies, Inc.
Jayson is a principal and founding member of Health Policy Strategies, Inc., and counsels clients on Medicare and Medicaid coverage, payment, reimbursement, coding, and government policies. He has experience leading pre- and post-launch strategies as well as lifecycle management tools for pharmaceutical, biotechnology, diagnostic, and device manufacturers. Jayson has previously served as Vice President of Reimbursement and Innovation Strategies for United BioSource Corporation (UBC) and maintained his own policy practice.